NHS Buyer Readiness
What NHS buyers need to see
Part sales enablement, part objection handling: the standards and artefacts that move a digital-health purchase through NHS governance — and how we help you prepare them.
Standards & artefacts
The assurance map
| Standard | Full name | What it covers |
|---|---|---|
| DTAC | Digital Technology Assessment Criteria | Baseline assessment across clinical safety, data protection, technical security, interoperability and usability/accessibility. |
| DCB0129 | Manufacturer clinical risk management | Clinical safety case and hazard log for the maker of a health IT system. |
| DCB0160 | Deployment clinical risk management | Local clinical risk management for the deploying healthcare organisation. |
| DPIA | Data Protection Impact Assessment | Required for high-risk processing, including large-scale special-category and certain AI uses. |
| DSP Toolkit | Data Security & Protection Toolkit | Expected for organisations with access to NHS patient data and systems. |
What we provide
- DTAC response preparation and review
- DCB0129 safety case & hazard log support
- DCB0160 deployment safety support
- DPIA structuring and review
- Capability statement tailored by sector
- Procurement routes-to-market guidance
What buyers are really assessing
Selling to the NHS is an assurance conversation
An NHS purchase of digital technology is rarely settled by the demo. Before a product reaches a ward it has to pass through clinical safety review, information governance, technical security, procurement and often a clinical reference group — each of which is asking a version of the same question: can we accept the residual risk of using this? The buyer's job is to protect patients and the organisation, so a feature list reassures them far less than evidence that the risks have been identified, controlled and documented by people who understand the standards.
This is why we frame buyer readiness as part sales enablement and part objection handling. Every artefact on the assurance map exists to answer an objection a governance committee will otherwise raise. A clinical safety case answers "how do we know this is safe in clinical use?" A DPIA answers "is the data being processed lawfully and proportionately?" A DTAC response answers all five core areas in the language NHS reviewers expect. When these arrive complete and coherent, the conversation shifts from whether the product can be bought to how quickly it can be deployed.
How we get you ready
From gap assessment to a defensible pack
- Gap assessment. We benchmark your current evidence against the assurance map and identify what is missing, thin or out of date.
- Prioritise the blockers. We sequence the work so the artefacts most likely to stall a sale — usually clinical safety and the DPIA — are addressed first.
- Build and quality-assure. We help produce or sharpen the DTAC response, safety case, hazard log, deployment file and data-protection evidence so each withstands scrutiny.
- Join the threads. We make sure manufacturer and deployment safety, governance and data protection reference one another consistently rather than contradicting.
- Package for procurement. We assemble a buyer pack and, where useful, a sector-tailored capability statement that a procurement team can act on.
This pathway connects to the rest of our trust framework: the standards themselves are explained in our regulatory and compliance overview, the safety artefacts in clinical safety and risk, and the data footing in data protection and security. For background reading, see what is NHS DTAC and what is a clinical safety case.
Answers
Frequently asked questions
What artefacts do NHS buyers typically ask for?
A DTAC response, clinical safety case and hazard log (DCB0129), evidence of deployment safety (DCB0160), a DPIA, DSP Toolkit status, and clear information governance. We help you assemble and quality-assure these.
What do you NOT claim?
We provide assurance support, evaluation and governance guidance. We do not issue regulatory approvals, act as your notified body, or replace your organisation's accountable sign-off. Regulatory applicability depends on intended use and deployment context.
Can you produce a capability statement for procurement?
Yes — see our Capability Statement, which can be tailored by sector for tender submissions.
Why do digital-health purchases stall in NHS governance?
Usually not on price, but on assurance. A purchase stalls when the clinical safety case is missing or thin, when the DPIA was never done, when DTAC answers are incomplete, or when manufacturer and deployment safety do not join up. Buyers cannot accept the residual risk without that evidence, so the deal sits in committee. We close those gaps before they surface.
How long does it take to become procurement-ready?
It depends on how much evidence already exists and the complexity of the product, particularly whether AI is involved. We begin with a gap assessment against the assurance map, then prioritise the artefacts most likely to block a sale. Many clients reach a credible buyer pack faster than expected because the work is sequenced so each artefact feeds the next.
Do we need all of these standards from day one?
Not necessarily all at once, but you should know which apply and have a credible plan for each. A buyer is reassured by a clear, honest roadmap as much as by completed documents. We help you decide what is essential before first sale and what can follow on a defined timeline.
Get procurement-ready
Request a procurement-oriented proposal or download the buyer pack.